EICHOR
● Active Not Recruiting
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56
Condition: Wet Age Related Macular Degeneration · wAMD · Sponsor: EyePoint Pharmaceuticals, Inc.
About this study
This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (76)
| Retinal Research Institute, LLC | Phoenix, Arizona, United States | — |
| Retina Partners of Northwest Arkansas | Springdale, Arkansas, United States | — |
| California Retina Consultants | Bakersfield, California, United States | — |
| Retina Vitreous Associates Medical Group | Beverly Hills, California, United States | — |
| Macula and Retina Institute | Glendale, California, United States | — |
| Retina Consultants San Diego | Poway, California, United States | — |
| Retina Consultants of Southern California | Redlands, California, United States | — |
| Retinal Consultants Medical Group | Sacramento, California, United States | — |
| Bay Area Retina Associates | Walnut Creek, California, United States | — |
| American Institute of Research | Whittier, California, United States | — |
| RSC Research, PLLC | Denver, Colorado, United States | — |
| Eye Center of Northern Colorado, PC | Fort Collins, Colorado, United States | — |
+ 64 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06668064